Loading, please wait...
University of South Carolina College of Pharmacy
Annual Continuing Education Conference
Day 2: Registration for Pharmacists
Saturday, February 22, 2020
8:00 am to 4:05 pm
Location: University of South Carolina College of Pharmacy, Coker Life Sciences Room 215, 715 Sumter Street, Columbia, SC 29208
Target Audience: Pharmacists and Pharmacy Technicians
Speakers and Topics:
* Please scroll down and expand all topics to view specific learning objectives for pharmacists or pharmacy technicians
Live Programming
 |
Jordan Cooler, PharmD, BCPP; Clinical Assistant Professor, University of South Carolina College of Pharmacy; Psychiatric Pharmacist, University of South Carolina Student Health Center
|
Drugs of Abuse: A Focused Update on Abuse and Monitoring
(8:30 am-9:30 am)
|
 |
Julie Sease, PharmD, FCCP; Senior Associate Dean and Professor,
University of South Carolina College of Pharmacy
|
Hypertension: Classification, Management, and Monitoring of the Most Common Disease State
(9:45 am-10:45 am)
|
 |
Cynthia Phillips, PharmD, CDE; Clinical Associate Professor, University of South Carolina College of Pharmacy; Clinical Pharmacist, Prisma Health Richland
|
Determining Decisions and Deciphering Dilemmas in Dyslipidemia with Updated
American College of Cardiology/American Heart Association Cholesterol Guidelines (10:50 am-11:50 am)
|
 |
Brie Dunn, PharmD; Associate Dean for Outcomes Assessment &
Accreditation and Clinical Associate Professor, University of South Carolina College of Pharmacy
|
Beyond Diabetes: Benefits of SGLT2 Inhibitors and GLP-1 Agonists
(12:45 pm-1:45 pm)
|
 |
Hana Rac Winders, PharmD, BCIDP; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC- SC); Clinical Assistant Professor, University of South Carolina College of Pharmacy
|
Community Acquired Pneumonia Update
(2:00 pm-3:00 pm)
|
 |
Jill Michels, PharmD, DABAT; Clinical Associate Professor, University of South Carolina College of Pharmacy; Managing Director, Palmetto Poison Center
|
Management of Pit Viper and Black Widow Envenomation
(3:05 pm-4:05 pm)
|
Home Study Programming Available to All Registrants
 |
Kathryn N. Anderson, PharmD;
PGY1 Community Pharmacy Resident, Medicine Mart Pharmacy
|
Immunized People 2020: An Immunization Update |
Registration Information:
- Registration will remain open until February 14, 2020 at 8:00 am
- Register online at https://cop.sc.learningexpressce.com - scroll down and select "Register Now" within the program!
Registration Fees:
- Early registration prior to January 6, 2020:
- Pharmacists (single day): $130
- Pharmacists (both days, 2/1 and 2/22): $230
- Pharmacy technicians (single day): $85
- Pharmacy technicians (both days, 2/1 and 2/22): $140
- Registration after January 6, 2020 will increase by $20:
- Pharmacists (single day): $150
- Pharmacists (both days, 2/1 and 2/22): $250
- Pharmacy technicians (single day): $105
- Pharmacy technicians (both days, 2/1 and 2/22): $160
- Fees include continental breakfast and lunch
-
Please note that fees will appear as “Learning Express” on your credit card statement
-
PEEP Preceptors: Prior to registering, please check your email for information from the PEEP Office on discounted registration!
Cancellations: USC COP reserves the right to cancel the entire program. In the event of a cancellation, each participant will be notified via email prior to the program and a full tuition refund will be made. All refunds should be requested in writing on or before January 17, 2020 and will be subject to a 7.5% administrative fee. No cancellation requests will be accepted after January 17, 2020.
CE Categories: This program has been accredited for 6.0 live contact hours (0.6 CEUs) and 1.0 home study contact hour (0.1 CEU) for pharmacists and pharmacy technicians. Six live hours qualify as “drug therapy or patient management”, with one of those hours designed to combat the opioid epidemic through pain management and “approved procedures for monitoring controlled substances”. The home study hour serves as an immunization update for immunizing pharmacists and will qualify as “drug therapy or patient management”.
Date: Feb 22, 2020 08:30 AM - 04:05 PM
Fee
$150.00
CE Hours
7.00
CE Units
0.700
Registration closes on Feb 18, 2020 02:00 PM
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants must sign in upon arrival and have attendance verified.
To claim credit for this activity, participants must complete the online program evaluations and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID. To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.
Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor. Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.
Registration closes on Feb 18, 2020
at 02:00 PM
Registration closes on Feb 18, 2020
at 02:00 PM
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Identify risk factors for inappropriate use of controlled substances and other prescription and non-prescription drugs of abuse
- Explain best practices for identifying and mitigating drug abuse and misuse based on available data
- Apply recommendations in a specific pharmacy practice setting
Speaker(s)/Author(s)
|
Jordan Cooler Haygood, PharmD, BCPP
|
Activity Number
0062-0000-20-007-L01-P
Date:
02/22/20
Time:
08:30 AM - 09:30 AM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Use patient case information to categorize a patient as having normal blood pressure, elevated blood pressure, stage 1 hypertension, or stage 2 hypertension and assign an appropriate evidence based blood pressure goal for the patient
- Recommend an appropriate initial evidence based treatment plan (including nonpharmacologic and pharmacologic therapies) for a patient based on their presenting blood pressure value and patient specific factors (including compelling indications, laboratory evaluation, and ASCVD risk)
- Justify an appropriate evidence based treatment plan for a patient who is not meeting blood pressure goal on their current regimen
- Educate a patient who will be conducting home blood pressure monitoring about the guideline-recommended way to complete this
Speaker(s)/Author(s)
|
Julie Sease, PharmD, FCCP, BCPS, CDCES, BCACP
|
Activity Number
0062-0000-20-008-L01-P
Date:
02/22/20
Time:
09:45 AM - 10:45 AM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Investigate patient risk of atherosclerotic cardiovascular disease (ASCVD) using risk calculators and risk enhancing factors
- Analyze updates in the American College of Cardiology (ACC) /American Heart Association (AHA) Cholesterol Guidelines
- Discuss the appropriate use of non-statin therapies in ASCVD prevention
- Apply updated ACC/AHA Cholesterol Guidelines to patient cases
Speaker(s)/Author(s)
|
Cynthia Phillips, PharmD, CDCES
|
Activity Number
0062-0000-20-009-L01-P
Date:
02/22/20
Time:
10:50 AM - 11:50 AM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Describe the advantages and disadvantages of SGLT2 inhibitors and GLP-1 agonists
- Identify potential benefits of SGLT2 inhibitors and GLP-1 agonists based on recent clinical trial data
- Compare and contrast cardiovascular and renal benefits for available SGLT2 inhibitors and GLP-1 agonists
- Develop and justify an evidence-based plan for a specific patient in order to provide cardiovascular and/or renal benefit. given a case scenario
Speaker(s)/Author(s)
|
Brie Dunn, PharmD
|
Activity Number
0062-0000-20-010-L01-P
Date:
02/22/20
Time:
12:45 PM - 01:45 PM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Identify the differences between the 2007 and 2019 community-acquired pneumonia (CAP) guidelines
- Discuss the evidence behind recommendations in the new CAP guidelines
- Apply the new CAP guidelines to patient cases
- Recognize the pharmacist's role in antimicrobial stewardship relating to the treatment of CAP
Speaker(s)/Author(s)
|
Hana Rac Winders, PharmD, BCIDP
|
Activity Number
0062-0000-20-011-L01-P
Date:
02/22/20
Time:
02:00 PM - 03:00 PM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Discuss treatment myths associated with pit viper envenomation.
- Recommend supportive treatment for pit viper envenomation.
- Compare Crotalidae Polyvalent Immune Fab (Ovine) antivenom to Crotalidae Immune F(ab’)2 (Equine) antivenom
- List treatment options for black widow spider bite
Speaker(s)/Author(s)
|
Jill Michels, PharmD, DABAT
|
Activity Number
0062-0000-20-012-L01-P
Date:
02/22/20
Time:
03:05 PM - 04:05 PM
CE Hours
1.00
Registration Closed
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
- Identify strategies to improve immunization rates
- Review recently published immunizations efficacy studies
- Determine a patient’s immunization needs based on disease states, exposures, and immunization history through a patient case
Speaker(s)/Author(s)
|
Kathryn N. Anderson, PharmD
|
Activity Number
0062-0000-20-013-H06-P
Release Date:
Feb 1, 2020
Credit Expiration Date:
Feb 1, 2021
CE Hours
1.00
Registration Closed